Longbow Finance’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.07M Buy
50,754
+6,287
+14% +$880K 1.28% 32
2025
Q4
$5.46M Sell
44,467
-48,344
-52% -$5.88M 0.92% 42
2025
Q3
$10.3M Buy
92,811
+24,044
+35% +$2.73M 1.02% 36
2025
Q2
$7.62M Buy
68,767
+9,390
+16% +$999K 0.81% 42
2025
Q1
$6.65M Buy
+59,377
New +$6.13M 0.8% 41

Other funds holding GILD

Longbow Finance's GILD Position: Q1 2026 in Review

Longbow Finance increased its Gilead Sciences (GILD) stake by 14% in Q1 2026, buying an estimated $880K and bringing the position to 50,754 shares worth $7.07M. The position accounts for 1.28% of the portfolio, ranked #32.

Longbow Finance first reported a position in GILD in Q1 2025 and has held it in 5 quarters since. The position peaked at $10.3M in Q3 2025. 2,310 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Longbow Finance held 50,754 shares of Gilead Sciences worth $7.07M as of Q1 2026.
  • Longbow Finance bought 6,287 Gilead Sciences shares in Q1 2026, an estimated $880K.
  • Gilead Sciences made up 1.28% of Longbow Finance's portfolio in Q1 2026, its #32 holding.
  • Longbow Finance first reported a position in Gilead Sciences in Q1 2025 and has held it in 5 quarters since.
  • Longbow Finance's Gilead Sciences position peaked at $10.3M in Q3 2025.
  • 2,310 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Longbow Finance's 13F filing for Q1 2026, filed 12 May 2026.